Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amanda L Elchynski

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
American Journal of Nephrology|September 14, 2020
Genotype-Guided Hydralazine TherapyKimberly S Collins, Anthony L J Raviele, Amanda L Elchynski, et al.
Journal of Personalized Medicine|November 27, 2021
Utilizing a Human-Computer Interaction Approach to Evaluate the Design of Current Pharmacogenomics Clinical Decision SupportAmanda L Elchynski, Nina Desai, Danielle D'Silva, et al.
Clinical Pharmacology and Therapeutics|July 7, 2021
How to Integrate CYP2D6 Phenoconversion Into Clinical Pharmacogenetics: A TutorialEmily J Cicali, Amanda L Elchynski, Kelsey J Cook, et al.
Journal of Personalized Medicine|April 23, 2022
Multidisciplinary Consulting Team for Complicated Cases of Neurodevelopmental and Neurobehavioral Disorders: Assessing the Opportunities and Challenges of Integrating Pharmacogenomics into a Team SettingPritmohinder S Gill, Amanda L Elchynski, Patricia A Porter-Gill, et al.
The Pharmacogenomics Journal|June 2, 2021
Determining the potential clinical value of panel-based pharmacogenetic testing in patients with chronic pain or gastroesophageal reflux diseaseAmanda L Elchynski, Emily J Cicali, Maria C Ferrer Del Busto, et al.
Clinical Pharmacology and Therapeutics|September 1, 2022
Expanded Clinical Pharmacogenetics Implementation Consortium Guideline for Medication Use in the Context of G6PD GenotypeRoseann S Gammal, Munir Pirmohamed, Andrew A Somogyi, et al.
Clinical and Translational Science|July 24, 2024
Implementation of a pharmacogenetic panel-based test for pharmacotherapy-based supportive care in an adult oncology clinicEmily J Cicali, Elizabeth Eddy, Yan Gong, et al.
Clinical Pharmacology and Therapeutics|September 20, 2025
Clinical Pharmacogenetics Implementation Consortium Guideline for NAT2 Genotype and Hydralazine TherapyMichael T Eadon, David W Hein, Michael A Andersen, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|July 20, 2021
Multisite investigation of strategies for the clinical implementation of pre-emptive pharmacogenetic testingJulio D Duarte, Rachel Dalton, Amanda L Elchynski, et al.
Clinical and Translational Science|September 25, 2021
Multisite evaluation of institutional processes and implementation determinants for pharmacogenetic testing to guide antidepressant therapySony Tuteja, Ramzi G Salloum, Amanda L Elchynski, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
American Journal of Nephrology|September 14, 2020
Genotype-Guided Hydralazine TherapyKimberly S Collins, Anthony L J Raviele, Amanda L Elchynski, et al.
Journal of Personalized Medicine|November 27, 2021
Utilizing a Human-Computer Interaction Approach to Evaluate the Design of Current Pharmacogenomics Clinical Decision SupportAmanda L Elchynski, Nina Desai, Danielle D'Silva, et al.
Clinical Pharmacology and Therapeutics|July 7, 2021
How to Integrate CYP2D6 Phenoconversion Into Clinical Pharmacogenetics: A TutorialEmily J Cicali, Amanda L Elchynski, Kelsey J Cook, et al.
Journal of Personalized Medicine|April 23, 2022
Multidisciplinary Consulting Team for Complicated Cases of Neurodevelopmental and Neurobehavioral Disorders: Assessing the Opportunities and Challenges of Integrating Pharmacogenomics into a Team SettingPritmohinder S Gill, Amanda L Elchynski, Patricia A Porter-Gill, et al.
The Pharmacogenomics Journal|June 2, 2021
Determining the potential clinical value of panel-based pharmacogenetic testing in patients with chronic pain or gastroesophageal reflux diseaseAmanda L Elchynski, Emily J Cicali, Maria C Ferrer Del Busto, et al.
Clinical Pharmacology and Therapeutics|September 1, 2022
Expanded Clinical Pharmacogenetics Implementation Consortium Guideline for Medication Use in the Context of G6PD GenotypeRoseann S Gammal, Munir Pirmohamed, Andrew A Somogyi, et al.
Clinical and Translational Science|July 24, 2024
Implementation of a pharmacogenetic panel-based test for pharmacotherapy-based supportive care in an adult oncology clinicEmily J Cicali, Elizabeth Eddy, Yan Gong, et al.
Clinical Pharmacology and Therapeutics|September 20, 2025
Clinical Pharmacogenetics Implementation Consortium Guideline for NAT2 Genotype and Hydralazine TherapyMichael T Eadon, David W Hein, Michael A Andersen, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|July 20, 2021
Multisite investigation of strategies for the clinical implementation of pre-emptive pharmacogenetic testingJulio D Duarte, Rachel Dalton, Amanda L Elchynski, et al.
Clinical and Translational Science|September 25, 2021
Multisite evaluation of institutional processes and implementation determinants for pharmacogenetic testing to guide antidepressant therapySony Tuteja, Ramzi G Salloum, Amanda L Elchynski, et al.
Pageof 2